Formulation of a killed whole cell pneumococcus vaccine - effect of aluminum adjuvants on the antibody and IL-17 response.
about
Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatisDistinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant.Mechanism of immunopotentiation and safety of aluminum adjuvants.Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults.Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention.Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action
P2860
Formulation of a killed whole cell pneumococcus vaccine - effect of aluminum adjuvants on the antibody and IL-17 response.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Formulation of a killed whole ...... e antibody and IL-17 response.
@ast
Formulation of a killed whole ...... e antibody and IL-17 response.
@en
type
label
Formulation of a killed whole ...... e antibody and IL-17 response.
@ast
Formulation of a killed whole ...... e antibody and IL-17 response.
@en
prefLabel
Formulation of a killed whole ...... e antibody and IL-17 response.
@ast
Formulation of a killed whole ...... e antibody and IL-17 response.
@en
P2093
P2860
P356
P1476
Formulation of a killed whole ...... e antibody and IL-17 response.
@en
P2093
Anisa Dunham
Bethany Hansen
Harm Hogenesch
Jean-Francois Maisonneuve
Kathleen Anderson
Stanley L Hem
P2860
P2888
P356
10.1186/1476-8518-9-5
P577
2011-07-29T00:00:00Z
P5875
P6179
1021516826